23 May 2013
Keywords: BioAlliance Pharma, Amep, Metastatic melanoma, Herlev Hospital
Article | 02 May 2012
French drugmaker BioAlliance Pharma (Euronext Paris: BIO) has announced the validation by the French drug agency the Afssaps of its ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
2 May 2012
1 May 2012
3 May 2012
© 2013 thepharmaletter.com